Literature DB >> 6459051

Gene dosage and suceptibility to insulin-dependent diabetes.

R S Spielman, L Baker, C M Zmijewski.   

Abstract

1. All members of 33 families in which two or more sibs have insulin-dependent diabetes mellitus (IDDM) were HLA-typed. The results strongly support the hypothesis that, closely linked to the HLA region, there is a locus (S) for susceptibility to IDDM. We use Sd for alleles at this locus which confer susceptibility to disease, and Sa for all other alleles. 2. Published prevalence (recurrence) rates for relatives of an IDDM proband, which are essential for the analysis, are reviewed critically, and a new estimate of prevalence at age 30 in the general population is calculated from published data. 3. The analysis allows for greater risk (penetrance) of the genotype SdSd (two doses of Sd) than of SaSd (one dose of Sd) and for recombination between the HLA region and S. With either our own data on 26 affected sib pairs or a much larger sample assembled by pooling with published data, the maximum-likelihood estimate of the two-dose penetrance is 71%, of the one dose penetrance 6.5%. The hypothesis of differential penetrance according to gene dosage provides a significantly better explanation than either simple dominant or simple recessive inheritance. 4. Estimates of the recombination fraction between HLA and S are very sensitive to the proportion of affected sib pairs sharing neither HLA haplotype, which varies considerably among the samples pooled. With the pooled data the recombination fraction is estimated as 3%, but in view of the strong associations with particular HLA alleles seen in population data, this should probably be considered an upper limit.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6459051     DOI: 10.1111/j.1469-1809.1980.tb00954.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  33 in total

1.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

Review 2.  Molecular mechanisms involved in the etiology and pathogenesis of autoimmune diseases.

Authors:  M Trucco
Journal:  Clin Investig       Date:  1992-09

3.  Familial risks in understanding type 1 diabetes genetics.

Authors:  Kari Hemminki
Journal:  Nat Rev Genet       Date:  2012-01-17       Impact factor: 53.242

4.  Determining the mode of inheritance of RFLP-associated diseases using the affected sib-pair method.

Authors:  G Thomson
Journal:  Am J Hum Genet       Date:  1986-08       Impact factor: 11.025

5.  Assessing the role of HLA-linked and unlinked determinants of disease.

Authors:  N Risch
Journal:  Am J Hum Genet       Date:  1987-01       Impact factor: 11.025

6.  Heterozygous expression of insulin-dependent diabetes mellitus (IDDM) determinants in the HLA system.

Authors:  N E Morton; A Green; T Dunsworth; A Svejgaard; J Barbosa; S S Rich; L Iselius; P Platz; L P Ryder
Journal:  Am J Hum Genet       Date:  1983-03       Impact factor: 11.025

7.  Epidemiology of childhood diabetes mellitus in Finland--background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. The Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  J Tuomilehto; R Lounamaa; E Tuomilehto-Wolf; A Reunanen; E Virtala; E A Kaprio; H K Akerblom
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

8.  The genotypic distribution among non-insulin-dependent diabetes mellitus (NIDDM) patients of a restriction fragment length polymorphism.

Authors:  G Thomson
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

9.  HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.

Authors:  P Platz; B K Jakobsen; N Morling; L P Ryder; A Svejgaard; M Thomsen; M Christy; H Kromann; J Benn; J Nerup; A Green; M Hauge
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

10.  HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study.

Authors:  S S Rich; L R French; J M Sprafka; J P Clements; F C Goetz
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.